Syndax Pharmaceuticals (NASDAQ:SNDX) Issues Earnings Results

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.64) EPS for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.09, Briefing.com reports. During the same quarter last year, the business posted ($0.62) EPS. Syndax Pharmaceuticals Stock Down 2.9 % SNDX traded down $0.59 during midday […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Blackrock ,Briggs Morrison ,William Meury ,Securities Exchange Commission ,Wellington Management Group ,Earnings History For Syndax Pharmaceuticals ,Citigroup ,Syndax Pharmaceuticals Inc ,Syndax Pharmaceuticals ,Dimensional Fund Advisors ,News Ratings For Syndax Pharmaceuticals Daily ,Institutional Trading Of Syndax Pharmaceuticals ,Barclays ,Vanguard Group Inc ,Scotiabank ,Syndax Pharmaceuticals Stock Down ,Blackrock Inc ,Get Free Report ,Pharmaceuticals Stock Down ,Director Briggs Morrison ,Exchange Commission ,Director William Meury ,Street Corp ,Management Group ,Fund Advisors ,Syndax Pharmaceuticals Daily ,Nasdaq Sndx ,Sndx ,Medical ,Earnings ,